Cella D - Search Results

1

Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Cella D, Basch E, Miladinovic B, Dearden L, Deprince K, Naini V, Lopez-Gitlitz A, Chi KN; TITAN investigators. Agarwal N, et al. Among authors: cella d. Lancet Oncol. 2019 Nov;20(11):1518-1530. doi: 10.1016/S1470-2045(19)30620-5. Epub 2019 Sep 29. Lancet Oncol. 2019. PMID: 31578173 Clinical Trial.

2

Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale.

Cella D. Cella D. Semin Oncol. 2003 Feb;30(1 Suppl 1):39-48. doi: 10.1053/sonc.2003.50031. Semin Oncol. 2003. PMID: 12644983

3

Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.

Hahn EA, Glendenning GA, Sorensen MV, Hudgens SA, Druker BJ, Guilhot F, Larson RA, O'Brien SG, Dobrez DG, Hensley ML, Cella D; IRIS Investigators. Hahn EA, et al. Among authors: cella d. J Clin Oncol. 2003 Jun 1;21(11):2138-46. doi: 10.1200/JCO.2003.12.154. J Clin Oncol. 2003. PMID: 12775739 Clinical Trial.

4

Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.

Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Fallowfield L, et al. Among authors: cella d. J Clin Oncol. 2004 Nov 1;22(21):4261-71. doi: 10.1200/JCO.2004.08.029. J Clin Oncol. 2004. PMID: 15514369

5

Quality of life considerations in patients with advanced lung cancer.

Cella D. Cella D. Semin Oncol. 2004 Dec;31(6 Suppl 11):16-20. doi: 10.1053/j.seminoncol.2004.10.004. Semin Oncol. 2004. PMID: 15599830 Review.

6

Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.

Monk BJ, Huang HQ, Cella D, Long HJ 3rd; Gynecologic Oncology Group Study. Monk BJ, et al. Among authors: cella d. J Clin Oncol. 2005 Jul 20;23(21):4617-25. doi: 10.1200/JCO.2005.10.522. Epub 2005 May 23. J Clin Oncol. 2005. PMID: 15911864 Clinical Trial.

7

Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.

McQuellon RP, Thaler HT, Cella D, Moore DH. McQuellon RP, et al. Among authors: cella d. Gynecol Oncol. 2006 May;101(2):296-304. doi: 10.1016/j.ygyno.2005.10.039. Epub 2006 Jan 10. Gynecol Oncol. 2006. PMID: 16376417 Clinical Trial.

8

Role of quality of life in men with metastatic hormone-refractory prostate cancer: how does atrasentan influence quality of life?

Cella D, Petrylak DP, Fishman M, Teigland C, Young J, Mulani P. Cella D, et al. Eur Urol. 2006 May;49(5):781-9. doi: 10.1016/j.eururo.2005.12.058. Epub 2006 Jan 19. Eur Urol. 2006. PMID: 16458417 Review.

9

Wenzel LB, Huang HQ, Armstrong DK, Walker JL, Cella D; Gynecologic Oncology Group. Wenzel LB, et al. Among authors: cella d. J Clin Oncol. 2007 Feb 1;25(4):437-43. doi: 10.1200/JCO.2006.07.3494. J Clin Oncol. 2007. PMID: 17264340 Clinical Trial.

10

Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial.

Cella D, Li JZ, Cappelleri JC, Bushmakin A, Charbonneau C, Kim ST, Chen I, Motzer RJ. Cella D, et al. J Clin Oncol. 2008 Aug 1;26(22):3763-9. doi: 10.1200/JCO.2007.13.5145. J Clin Oncol. 2008. PMID: 18669464 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,182 results

Search Page